Society of Interventional Radiology Multisociety Consensus Position Statement on Prostatic Artery Embolization for Treatment of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: From the Society of Interventional Radiology, the Cardiovascular and Interventional Radiological Society of Europe, Société Française de Radiologie, and the British Society of Interventional Radiology: Endorsed by the Asia Pacific Society of Cardiovascular and Interventional Radiology, Canadian Association for Interventional Radiology, Chinese College of Interventionalists, Interventional Radiology Society of Australasia, Japanese Society of Interventional Radiology, and Korean Society of Interventional Radiology

Justin P. McWilliams, Tiago A. Bilhim, Francisco C. Carnevale, Shivank Bhatia, Ari J. Isaacson, Sandeep Bagla, Marc R. Sapoval, Jafar Golzarian, Riad Salem, Timothy D. McClure, Bruce R. Kava, James B. Spies, Tarun Sabharwal, Ian McCafferty, Alda L. Tam

Research output: Contribution to journalArticlepeer-review

73 Scopus citations
Original languageEnglish (US)
Pages (from-to)627-637.e1
JournalJournal of Vascular and Interventional Radiology
Issue number5
StatePublished - May 2019

Bibliographical note

Funding Information:
J.P.M. receives personal fees from Boston Scientific (Marlborough, Massachusetts) and Merit Medical (South Jordan, Utah). T.A.B. receives personal fees from Philips (Eindhoven, The Netherlands), Merit Medical, Embolx (Sunnyvale, California), and Terumo (Tokyo, Japan). S.Bh. receives grants and personal fees from Merit Medical and Siemens (Munich, Germany) and personal fees from Embolx and Terumo. A.J.I. receives grants and personal fees from BTG International (London, United Kingdom), grants from Medtronic (Dublin, Ireland), and personal fees from Cook (Bloomington, Indiana), Terumo, ABK Biomedical (Halifax, Nova Scotia, Canada), Boston Scientific, and CrannMed (Galway, Ireland). S.Ba. receives grants and personal fees from Medtronic, Terumo, and Boston Scientific and personal fees from Teleflex (Wayne, Pennsylvania). R.S. receives grants and personal fees from BTG International and personal fees from Eisai (Tokyo, Japan), Bristol-Myers Squibb (New York, New York), and Boston Scientific. B.R.K. is a paid speaker for Merit Medical (Los Angeles, California). None of the other authors have identified a conflict of interest.

Cite this